Clinical Trials

• Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment
  ClinicalTrials.gov Identifier: NCT00288925 - Active, not recruiting
  Pancreatic Cancer
  
• Z-Joint Changes in Low Back Pain Following Adjusting
  ClinicalTrials.gov Identifier: NCT00284063 - Recruiting
  Mechanical Low Back Pain
  
• ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00312377 - Recruiting
  Non-Small Cell Lung Cancer; Lung Cancer
  
• Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
  ClinicalTrials.gov Identifier: NCT00441142 - Recruiting
  Glioblastoma Multiforme; Gliosarcoma
  
• Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00460551 - Recruiting
  Non Small Cell Lung Cancer
  
• Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00401401 - Recruiting
  Head and Neck Cancer; Squamous Cell Cancer
  
• Zalutumumab in Non-Curable Patients With SCCHN
  ClinicalTrials.gov Identifier: NCT00542308 - Active, not recruiting
  Head and Neck Cancer; Squamous Cell Cancer
  
• Zalutumumab in Patients With Non-Curable Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00382031 - Recruiting
  Head and Neck Cancer; Squamous Cell Cancer
  
• Zambia Exclusive Breastfeeding Study
  ClinicalTrials.gov Identifier: NCT00310726 - Active, not recruiting
  HIV Infection
  
• Zambia Integrated Management of Malaria and Pneumonia Study
  ClinicalTrials.gov Identifier: NCT00513500 - Not yet recruiting
  Community Health Care
  
• ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00415779 - Recruiting
  Metastatic Prostate Cancer
  
• Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00040105 - Active, not recruiting
  Leukemia, Myeloid, Chronic
  
• ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00014144 - Active, not recruiting
  recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
  
• ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
  ClinicalTrials.gov Identifier: NCT00016991 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer That Has Not Responded to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00030524 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• ZD 1839 in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00025207 - Completed
  recurrent malignant mesothelioma; advanced malignant mesothelioma; sarcomatous mesothelioma; epithelial mesothelioma
  
• ZD 1839 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00012337 - Completed
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• ZD 1839 in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00014170 - Active, not recruiting
  adult glioblastoma multiforme
  
• ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00025116 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• ZD 1839 in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00025350 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• ZD 1839 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00023699 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• ZD 1839 in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00033579 - Active, not recruiting
  recurrent prostate cancer
  
• ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00014183 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00026364 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00016172 - Active, not recruiting
  Leukemia; Lymphoma; Eye Cancer
  
• ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021008 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
  
• ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
  ClinicalTrials.gov Identifier: NCT00054691 - Active, not recruiting
  Skin Cancer
  
• ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00252798 - Completed
  Non Small Cell Lung Carcinoma
  
• ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer
  ClinicalTrials.gov Identifier: NCT00242762 - Completed
  Head and Neck Cancer
  
• ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00247481 - Completed
  Breast Cancer
  
• ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00132158 - Recruiting
  Glioblastoma; Rhabdomyosarcomas; Neuroblastoma; Osteosarcoma
  
• ZD1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00015964 - Completed
  Nose Cancer; Oral Cancer; Throat Cancer
  
• ZD1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006049 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
  
• ZD1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006048 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00328562 - Recruiting
  Non-Small-Cell Lung Carcinoma (NSCLC)
  
• ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
  ClinicalTrials.gov Identifier: NCT00090363 - Active, not recruiting
  Prostate Cancer
  
• ZD4054 in Treating Patients With Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00107146 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00496665 - Recruiting
  Metastatic Breast Cancer
  
• ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
  ClinicalTrials.gov Identifier: NCT00404924 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00533169 - Active, not recruiting
  Neuroblastoma
  
• ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00071188 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
  Non-small cell lung cancer
  
• ZD6474 Compared With Gefitinib in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00072423 - No longer recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• ZD6474 in Treating Patients With Recurrent or Progressive Gliomas
  ClinicalTrials.gov Identifier: NCT00293566 - Recruiting
  Brain and Central Nervous System Tumors
  
• ZD6474 in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00066313 - Active, not recruiting
  extensive stage small cell lung cancer; limited stage small cell lung cancer
  
• ZD6474 Phase IIa Dose Finding Multicentre Study
  ClinicalTrials.gov Identifier: NCT00252746 - Completed
  Non Small Cell Lung Carcinoma
  
• ZD6474 With Radiation or Concomitantly With Weekly Cisplatin and Radiation Therapy, Stage III-IV Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00411710 - Recruiting
  Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Hypopharynx; Squamous Cell Carcinoma of the Larynx
  
• ZD6474(Vandetanib) + Alimta Combo Study
  ClinicalTrials.gov Identifier: NCT00506051 - Active, not recruiting
  Carcinoma; Non-Small Cell Lung; Lung Cancer
  
• ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00093392 - Recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00436072 - Recruiting
  Colorectal Cancer
  
• ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00014690 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Zemaira in Subjects With Emphysema Due to API Deficiency
  ClinicalTrials.gov Identifier: NCT00261833 - Recruiting
  Alpha1-Proteinase Inhibitor Deficiency
  
• Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
  ClinicalTrials.gov Identifier: NCT00091975 - Completed
  Kidney Disease
  
• Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00071838 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Zenapax to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00001934 - Active, not recruiting
  Multiple Sclerosis
  
• Zenith® AAA Endovascular Graft Clinical Study
  ClinicalTrials.gov Identifier: NCT00196092 - Completed
  Abdominal Aortic Aneurysm
  
• Zero Calorie Drink Products
  ClinicalTrials.gov Identifier: NCT00525694 - Recruiting
  Obesity
  
• Zestra in Women with Mixed Sexual Dysfunction
  ClinicalTrials.gov Identifier: NCT00118495 - Completed
  Hypoactive Sexual Desire Disorder; Sexual Arousal Disorder; Orgasmic Disorder
  
• Zevalin and BEAM High-Dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin’s Lymphoma
  ClinicalTrials.gov Identifier: NCT00463463 - Not yet recruiting
  Non-Hodgkin’s Lymphoma
  
• Zevalin-Beam for Aggressive Lymphoma
  ClinicalTrials.gov Identifier: NCT00491491 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00514475 - Recruiting
  Mantle Cell Lymphoma
  
• Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma
  ClinicalTrials.gov Identifier: NCT00168727 - Completed
  Lymphoma, Non-Hodgkin; Lymphoma, Low-Grade
  
• Ziconotide Effectiveness and Safety Trial in Patients with Chronic Severe Pain
  ClinicalTrials.gov Identifier: NCT00076544 - Active, not recruiting
  Pain
  
• Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
  ClinicalTrials.gov Identifier: NCT00199979 - Recruiting
  Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%
  
• Zidovudine and Lamivudine Given Once Versus Twice Daily
  ClinicalTrials.gov Identifier: NCT00014014 - Active, not recruiting
  HIV Infections
  
• Zidovudine Levels in HIV Infected Patients Being Treated for HCV
  ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00006264 - Completed
  AIDS-related primary CNS lymphoma
  
• Zidovudine Plus Lamivudine in HTLV-I-Associated Myelopathy: a Randomised Trial
  ClinicalTrials.gov Identifier: NCT00272480 - Completed
  HTLV-I-Associated Myelopathy
  
• Zileuton and Exhaled Nitric Oxide in Asthmatics
  ClinicalTrials.gov Identifier: NCT00575861 - Completed
  Asthma
  
• Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00262405 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
  ClinicalTrials.gov Identifier: NCT00493974 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Zinc & Bone Health in Thalassemia: The Think Zinc Study
  ClinicalTrials.gov Identifier: NCT00459732 - Recruiting
  Thalassemia
  
• Zinc and Pneumonia Protocol
  ClinicalTrials.gov Identifier: NCT00133432 - Terminated
  Respiratory Infections, Acute
  
• Zinc as Adjunct to Treatment of Pneumonia
  ClinicalTrials.gov Identifier: NCT00513929 - Not yet recruiting
  Pneumonia
  
• Zinc Deficiency in HIV - 1
  ClinicalTrials.gov Identifier: NCT00149552 - Active, not recruiting
  HIV; alcohol & drug use; zinc; zinc deficiency
  
• Zinc Homeostasis and Kinetics in Children with Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00104494 - Recruiting
  Cystic Fibrosis
  
• Zinc in Childhood Pneumonia
  ClinicalTrials.gov Identifier: NCT00252304 - Recruiting
  Pneumonia
  
• Zinc Pneumonia Outpatient Trial in Children < 2 Years
  ClinicalTrials.gov Identifier: NCT00142285 - Recruiting
  Pneumonia
  
• Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00036881 - Completed
  Head and Neck Cancer; oral complications of cancer and cancer therapy; radiation toxicity
  
• Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
  ClinicalTrials.gov Identifier: NCT00395226 - Recruiting
  Rosacea
  
• Zinc Supplementation in Cholera Patients
  ClinicalTrials.gov Identifier: NCT00226616 - Completed
  Cholera
  
• Zinc Supplementation in Shigella Patients
  ClinicalTrials.gov Identifier: NCT00321126 - Completed
  Testing Effect of Intervention
  
• Zinc Supplements in Lowering Cadmium Levels in Smokers
  ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Zinc to Improve Bone Health in People With Thalassemia (The Think Zinc Study)
  ClinicalTrials.gov Identifier: NCT00480415 - Recruiting
  Thalassemia
  
• Zinc, Mental Health, and School Performance in Guatemalan Schoolchildren
  ClinicalTrials.gov Identifier: NCT00283660 - Active, not recruiting
  Depression; Anxiety
  
• Zinc-ORS in Severe and Complicated Acute Diarrhea
  ClinicalTrials.gov Identifier: NCT00370968 - Recruiting
  Diarrhea; Dehydration
  
• Zink and Bone Strength
  ClinicalTrials.gov Identifier: NCT00317863 - Completed
  Coxarthrosis; Fracture of Femoral Neck
  
• Ziprasidone and Sertraline in PTSD
  ClinicalTrials.gov Identifier: NCT00248261 - Recruiting
  Post-Traumatic Stress Disorder
  
• Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00351000 - Completed
  Schizophrenia
  
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00338949 - Recruiting
  Schizophrenia; Metabolic Syndrome X; Insulin Resistance
  
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00374543 - Recruiting
  Generalized Anxiety Disorder; Bipolar Disorder
  
• Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181922 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Ziprasidone in Children With Autism: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00208559 - Active, not recruiting
  Autism
  
• Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00239109 - Completed
  Schizophrenia
  
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
  ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
  Affective Disorders
  
• ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00555919 - Not yet recruiting
  Metastatic Breast Cancer Stage IV
  
• ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00325351 - Recruiting
  Ovarian Neoplasms
  
• ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00350051 - Recruiting
  Prostate Cancer
  
• ZK219477 in Patients With Breast Cancer and Brain Metastases
  ClinicalTrials.gov Identifier: NCT00496379 - Recruiting
  Breast Cancer; CNS Disease
  
• ZK283197 for Treatment of Vasomotor Symptoms
  ClinicalTrials.gov Identifier: NCT00537836 - Not yet recruiting
  Vasomotor Symptoms (Hot Flushes)
  
• Zmax Compared to Augmentin in Sinusitis
  ClinicalTrials.gov Identifier: NCT00367120 - Completed
  Sinusitis
  
• Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media
  ClinicalTrials.gov Identifier: NCT00360100 - Completed
  Otitis Media
  
• Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00039104 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Zoledronate and Estradiol in Preventing Bone Loss in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00049491 - Recruiting
  Osteoporosis; stage III prostate cancer; stage IV prostate cancer
  
• Zoledronate in Preventing Bone Loss Caused By Long-Term Androgen Deprivation Therapy in Patients With Stage III or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058188 - Recruiting
  Hypercalcemia; stage III prostate cancer; stage IV prostate cancer
  
• Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00107263 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00049452 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer
  
• Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00329797 - Recruiting
  Osteoporosis; Prostate Cancer
  
• Zoledronate in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00321932 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Osteoporosis; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00301873 - Active, not recruiting
  Brain and Central Nervous System Tumors; Osteoporosis
  
• Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00079001 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00295867 - Recruiting
  Breast Cancer
  
• Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00436917 - Active, not recruiting
  Breast Cancer; Osteoporosis
  
• Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
  ClinicalTrials.gov Identifier: NCT00278434 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00003884 - Active, not recruiting
  Pain; bone metastases; Recurrent Small Cell Lung Cancer; unspecified adult solid tumor, protocol specific; recurrent non-small cell lung cancer; ...
  
• Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00301886 - Completed
  Breast Cancer; Hypercalcemia; Metastatic Cancer; Pain; Quality of Life
  
• Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
  ClinicalTrials.gov Identifier: NCT00305695 - Recruiting
  Hereditary Breast/Ovarian Cancer (brca1, brca2); Osteoporosis; Ovarian Cancer
  
• Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
  ClinicalTrials.gov Identifier: NCT00005073 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer; Quality of Life
  
• Zoledronate With Atorvastatin In Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00490698 - Recruiting
  Kidney Cancer; Renal Cell Carcinoma
  
• Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00432458 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022087 - Active, not recruiting
  Breast Cancer; Osteoporosis
  
• Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00127205 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00365105 - Recruiting
  Breast Cancer; Lung Cancer; Metastatic Cancer; Pain; Prostate Cancer
  
• Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
  ClinicalTrials.gov Identifier: NCT00206388 - Recruiting
  Neuroblastoma
  
• Zoledronic Acid Administration to Metastatic Breast Cancer Patients with Non-Symptomatic Bone Lesions.
  ClinicalTrials.gov Identifier: NCT00130494 - Terminated
  Breat Cancer
  
• Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00559897 - Not yet recruiting
  Lung Cancer; Metastatic Cancer
  
• Zoledronic Acid for Osteoporosis in the Elderly
  ClinicalTrials.gov Identifier: NCT00558012 - Not yet recruiting
  Osteoporosis; Bone Loss; Fragility Fractures
  
• Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00216151 - Terminated
  Multiple Myeloma
  
• Zoledronic Acid in the Prevention of Skeletal-Related Events in Hormone Refractory and Hormone-Sensitive Prostate Cancer Patients With Bone Metastases
  ClinicalTrials.gov Identifier: NCT00219219 - Completed
  Prostate Cancer
  
• Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow
  ClinicalTrials.gov Identifier: NCT00172068 - Recruiting
  Primary Breast Cancer
  
• Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00181584 - Active, not recruiting
  Bone Loss; Prostate Cancer
  
• Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee
  ClinicalTrials.gov Identifier: NCT00477217 - Not yet recruiting
  Osteonecrosis
  
• Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00297830 - Recruiting
  Heart Transplantation; Bone Resorption
  
• Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00226954 - Recruiting
  Prostate Cancer
  
• Zolip 0501: Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
  ClinicalTrials.gov Identifier: NCT00349375 - Recruiting
  Hyperlipidemia
  
• Zolip 0502: Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
  ClinicalTrials.gov Identifier: NCT00352183 - Recruiting
  Cardiovascular Diseases
  
• Zometa - Femara Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women with Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
  ClinicalTrials.gov Identifier: NCT00050011 - Active, not recruiting
  Breast Neoplasms; Osteoporosis
  
• Zometa and Circulating VEGF in Breast Cancer Patients With Bone Metastasis
  ClinicalTrials.gov Identifier: NCT00524849 - Recruiting
  Metastatic Breast Cancer; Bone Metastases
  
• Zometa for the Management of Tumor-Induced Hypercalcemia and Malignant Bone Pain in the Community
  ClinicalTrials.gov Identifier: NCT00126386 - Completed
  Cancer; Hypercalcemia; Pain
  
• Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
  ClinicalTrials.gov Identifier: NCT00582556 - Recruiting
  Prostate Cancer
  
• ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
  ClinicalTrials.gov Identifier: NCT00294437 - Terminated
  Prostate Cancer
  
• Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00203450 - Active, not recruiting
  Obesity
  
• Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
  ClinicalTrials.gov Identifier: NCT00221442 - Active, not recruiting
  Binge Eating Disorder Associated With Obesity
  
• Zonisamide for Fibromyalgia & Migraine
  ClinicalTrials.gov Identifier: NCT00259636 - Recruiting
  Fibromyalgia; Migraine
  
• Zonisamide for Weight Reduction in Obese Adults
  ClinicalTrials.gov Identifier: NCT00275834 - Recruiting
  Obesity
  
• Zoom Study: Ziprasidone And Olanzapine's Outcomes In Mania
  ClinicalTrials.gov Identifier: NCT00329108 - Recruiting
  Bipolar Disorder
  
• Zostavax(R) Local Registration Trial
  ClinicalTrials.gov Identifier: NCT00444860 - Completed
  Varicella-Zoster Virus
  
• ZOSTAVAX(TM) Administered Concomitantly With PNEUMOVAX(TM) 23
  ClinicalTrials.gov Identifier: NCT00535730 - Recruiting
  Herpes Zoster; Pneumococcal Infection
  
• ZOSTAVAX(TM) in Patients on Chronic/Maintenance Corticosteroids
  ClinicalTrials.gov Identifier: NCT00546819 - Recruiting
  Herpes Zoster
  
• ZOSTAVAX(TM) Safety Study in Subjects 60 Years of Age or Older
  ClinicalTrials.gov Identifier: NCT00550745 - Recruiting
  Herpes Zoster
  
• Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Versus PacliTaxel-Eluting Stent for Coronary Lesions
  ClinicalTrials.gov Identifier: NCT00418067 - Recruiting
  Coronary Artery Disease
  
• Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients
  ClinicalTrials.gov Identifier: NCT00422565 - Recruiting
  Myocardial Infarction
  
• Zotepine Versus Risperidone in Aggressive Schizophrenic Patients in an Acute Ward
  ClinicalTrials.gov Identifier: NCT00418873 - Recruiting
  Schizophrenia
  
• ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
  ClinicalTrials.gov Identifier: NCT00283361 - Terminated
  Heart Failure, Congestive
  
• Zylet vs TobraDex in Blepharokeratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00447577 - Completed
  Blepharokeratoconjunctivitis
  
• Zyprexa and Task Engagement in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00440843 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Zytromax EV in CAP
  ClinicalTrials.gov Identifier: NCT00137007 - Completed
  Pneumonia